The recent observation that lower relative counts of cytotoxic CD8+ cells and higher relative counts of regulatory FOXP3+ T cells were associated with increased breast cancer risk [3] indicates that the effect of the host immune response on disease progression may be observable at a relatively early stage in the natural history of breast cancer. The gene discussed is CD8A; the disease is breast cancer.